Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Oct;58(4):933-41.
doi: 10.1172/JCI108546.

Rheumatoid factor-producing cells detected by direct hemolytic plaque assay

J H Vaughan, T Chihara, T L Moore, D L Robbins, K Tanimoto, J S Johnson, R McMillan

Rheumatoid factor-producing cells detected by direct hemolytic plaque assay

J H Vaughan et al. J Clin Invest. 1976 Oct.

Abstract

Lymphocytes secreting anti-IgC antibodies, rheumatoid factors (RF), can be detected in the peripheral bloods, synovial fluids, and bone marrows of patients with seropositive rheumatoid arthritis by using a direct plaque-forming cell (PFC) assay with sheep erythrocytes sensitized with reduced and alkylated rabbit IgG hemolysin. The autospecific nature of the RF produced by RF-PFC was indicated by inhibition studies in which the order of patency was human IgG greater than rabbit IgG greater than bovine IgG. In metabolic studies puromycin, cycloheximide, and venblastine suppressed RF-PFC. Cyclic AMP and cyclic GMP were without effect. A need was recognized for using full tissue culture media during the cell separation and plaquing procedures to optimize detection of the RF-PFC. RF-PFC may appear in the blood of patients intermittently despite their continuing presence in the bone marrow. They have been found in the peripheral blood, especially during acutely exacerbating polyarticular synovitis, generalized vasculities, or generally active, aggressive disease. RF-PFC were found in synovial effusions of new or recrduescent acute synovitis. RF-PFC were observed to disappear from the peripheral circulation and the bone marrow during therapy with cytotoxic drugs. The data are consistent with the hypothesis that the appearance of RF-PFC in the peripheral blood represents an anamnestic response to transiently appearing antigen. The nature of the antigen is not specified. The bone marrow may be a site of origin of RF-PFC.

PubMed Disclaimer

References

    1. Ann Rheum Dis. 1963 Jan;22(1):1-10 - PubMed
    1. Proc Soc Exp Biol Med. 1956 May;92(1):198-200 - PubMed
    1. Proc Soc Exp Biol Med. 1949 Nov;72(2):316-23 - PubMed
    1. Immunology. 1965 Feb;8:144-59 - PubMed
    1. Proc Soc Exp Biol Med. 1964 Nov;117:526-30 - PubMed

Publication types